215 related articles for article (PubMed ID: 8207561)
1. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
Kiowski W; Linder L; Erne P
J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
[TBL] [Abstract][Full Text] [Related]
2. [Endothelin-induced vasoconstriction in man: variable modification caused by endothelium-derived relaxing factor, Sodium nitroprusside and calcium antagonists].
Kiowski W; Linder L; Lüscher TF; Bühler FR
Schweiz Med Wochenschr; 1992 Apr; 122(15):559-62. PubMed ID: 1566022
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.
Kiowski W; Lüscher TF; Linder L; Bühler FR
Circulation; 1991 Feb; 83(2):469-75. PubMed ID: 1846783
[TBL] [Abstract][Full Text] [Related]
4. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
[TBL] [Abstract][Full Text] [Related]
5. Reversal of endothelin-1-induced vasoconstriction by nifedipine in human resistance vessels in vivo in healthy subjects.
Kiowski W; Linder L
Am J Cardiol; 1992 Apr; 69(12):1063-6. PubMed ID: 1561979
[TBL] [Abstract][Full Text] [Related]
6. Interactions of nifedipine with the renovascular effects of endothelin in humans.
Kaasjager KA; van Rijn HJ; Koomans HA; Rabelink TJ
J Pharmacol Exp Ther; 1995 Oct; 275(1):306-11. PubMed ID: 7562563
[TBL] [Abstract][Full Text] [Related]
7. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
9. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.
Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M
Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129
[TBL] [Abstract][Full Text] [Related]
10. Ouabain-induced elevation in forearm vascular resistance, calcium entry and alpha-adrenoceptor blockade, and release and removal of noradrenaline.
Schulte KL; van Gemmeren D; Thiede HM; Meyer-Sabellek W; Gotzen R; Distler A
J Hypertens Suppl; 1987 Dec; 5(5):S215-8. PubMed ID: 2895170
[TBL] [Abstract][Full Text] [Related]
11. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
Fujita T; Ito Y; Noda H; Sato Y; Ando K; Kangawa K; Matsuo H
J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension.
Sudano I; Virdis A; Taddei S; Spieker L; Corti R; Noll G; Salvetti A; Luscher TF
Hypertension; 2007 Feb; 49(2):285-90. PubMed ID: 17178974
[TBL] [Abstract][Full Text] [Related]
13. Effects of inhibition of ATP-sensitive potassium channels on metabolic vasodilation in the human forearm.
Farouque HM; Meredith IT
Clin Sci (Lond); 2003 Jan; 104(1):39-46. PubMed ID: 12519086
[TBL] [Abstract][Full Text] [Related]
14. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
Abernethy DR; Laurie N; Andrawis NS
Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
[TBL] [Abstract][Full Text] [Related]
15. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vasoconstriction by insulin.
van Veen S; Chang PC
J Hypertens; 1998 Aug; 16(8):1157-64. PubMed ID: 9794720
[TBL] [Abstract][Full Text] [Related]
17. In-vivo effects of endothelin-1 and ETA receptor blockade on arterial, venous and capillary functions in skeletal muscle.
Ekelund U; Albert U; Edvinsson L; Mellander S
Acta Physiol Scand; 1993 Jul; 148(3):273-83. PubMed ID: 8213182
[TBL] [Abstract][Full Text] [Related]
18. Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humans.
Haynes WG; Strachan FE; Gray GA; Webb DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S40-3. PubMed ID: 8587426
[TBL] [Abstract][Full Text] [Related]
19. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
20. Activation of the ATP-dependent potassium channel attenuates norepinephrine-induced vasoconstriction in the human forearm.
Pickkers P; Jansen Van Rosendaal AJ; Van Der Hoeven JG; Smits P
Shock; 2004 Oct; 22(4):320-5. PubMed ID: 15377886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
